We are live on ! Find out more

1,439 hedge funds and large institutions have $72.9B invested in Cigna in 2022 Q2 according to their latest regulatory filings, with 161 funds opening new positions, 502 increasing their positions, 488 reducing their positions, and 74 closing their positions.

New
Increased
Maintained
Reduced
Closed

118% more first-time investments, than exits

New positions opened: 161 | Existing positions closed: 74

71% more funds holding in top 10

Funds holding in top 10: 3153 (+22)

63% more call options, than puts

Call options by funds: $2.1B | Put options by funds: $1.28B

9% more capital invested

Capital invested by funds: $67B → $72.9B (+$5.94B)

5% more funds holding

Funds holding: 1,3731,439 (+66)

3% more repeat investments, than reductions

Existing positions increased: 502 | Existing positions reduced: 488

0.09% more ownership

Funds ownership: 87.01%87.1% (+0.09%)

Holders
1,439
Holders Change
+66
Holders Change %
+4.81%
% of All Funds
24.15%
Holding in Top 10
53
Holding in Top 10 Change
+22
Holding in Top 10 Change %
+70.97%
% of All Funds
0.89%
New
161
Increased
502
Reduced
488
Closed
74
Calls
$2.1B
Puts
$1.28B
Net Calls
+$813M
Net Calls Change
-$136M

CI Hedge Fund Activity: Q2 2022 in Review

1,439 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Cigna (CI) for Q2 2022, worth a combined $72.9B — up 8.9% from $67B a quarter earlier.

Buyers outnumbered sellers: 161 funds opened new CI positions and 74 closed out — a net gain of 87 holders — while 502 added to existing stakes and 488 trimmed.

The largest buyer was Putnam Investments, adding an estimated $408M. The largest seller was T. Rowe Price Associates, cutting an estimated $477M.

  • 1,439 institutional investors held Cigna (CI) as of Q2 2022, up from 1,373 in Q1 2022.
  • Funds reported $72.9B of Cigna stock for Q2 2022, up 8.9% quarter-over-quarter.
  • 161 funds opened new Cigna positions in Q2 2022 and 74 closed out, a net change of +87 holders.
  • The largest Cigna buyer in Q2 2022 was Putnam Investments, an estimated $408M added.
  • The largest Cigna seller in Q2 2022 was T. Rowe Price Associates, an estimated $477M sold.

Based on aggregated 13F filings for Q2 2022.